CDRH 2006 Priorities Reflect Urgency Of Device Postmarket Issues
This article was originally published in The Gray Sheet
Executive Summary
CDRH's fiscal year 2006 priorities highlight the pressing need to address postmarket device safety concerns following the string of cardiac rhythm management product recalls this summer
You may also be interested in...
Critical Path Will Lead To Device Research Opportunities In ’06 – Woodcock
A formal Critical Path priority list to be released in the coming year will include device-focused initiatives, assured FDA Deputy Commissioner for Operations Janet Woodcock
Critical Path Will Lead To Device Research Opportunities In ’06 – Woodcock
A formal Critical Path priority list to be released in the coming year will include device-focused initiatives, assured FDA Deputy Commissioner for Operations Janet Woodcock
FDA Premarket Activity Safe From Current Political Storm – Ex Chief Counsel
Current public pressure on the FDA in the wake of a string of high-profile safety problems for both drugs and devices will not make the agency more restrained in approving premarket applications, according to one former top FDA official